Aditxt, Inc. Treasury Stock, Value, Acquired, Cost Method
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- Aditxt, Inc. treasury stock, value, acquired, cost method for the quarter ending 2020-03-31 was $11.98K.
- Aditxt, Inc. treasury stock, value, acquired, cost method for the quarter ending 2019-09-30 was $110.89K.
- Aditxt, Inc. treasury stock, value, acquired, cost method for the quarter ending 2019-06-30 was $90.71K.
- Aditxt, Inc. treasury stock, value, acquired, cost method for fiscal 2020 was $11.98K, a 93.68% decline from fiscal 2019.
- Aditxt, Inc. treasury stock, value, acquired, cost method for fiscal 2019 was $189.63K.
| Period end | Treasury Stock, Value, Acquired, Cost Method 3 month | Treasury Stock, Value, Acquired, Cost Method 12 month |
|---|---|---|
| 2020-12-31 | $11.98K 10-K · filed 2021-03-25 | |
| 2020-03-31 | $11.98K 10-Q · filed 2021-05-12 | |
| 2019-12-31 | $189.63K 10-K · filed 2021-03-25 | |
| 2019-09-30 | $110.89K 10-Q · filed 2020-11-13 | |
| 2019-06-30 | $90.71K 10-Q · filed 2020-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |